Filing Details
- Accession Number:
- 0001250853-13-000111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-07 20:20:46
- Reporting Period:
- 2013-11-05
- Filing Date:
- 2013-11-07
- Accepted Time:
- 2013-11-07 20:20:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1425205 | Lion Biotechnologies Inc. | LBIO | Arrangement Of Transportation Of Freight & Cargo (4731) | 753254381 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1550588 | Manish Singh | 21900 Burbank Boulevard, 3Rd Floor Woodland Hills CA 91367 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-05 | 607,500 | $0.00 | 1,813,500 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2013-11-05 | 125,000 | $2.00 | 1,938,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Acquisiton | 2013-11-05 | 125,000 | $0.00 | 125,000 | $2.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
125,000 | 2013-11-05 | 2018-11-05 | No | 4 | A | Direct |
Footnotes
- These shares were issued to the reporting person pursuant to a merger agreement between Lion Biotechnologies, Inc. and Genesis Biopharma, Inc. dated July 24, 2013 whereby upon the completion of a financing within 12 months following the merger, additional shares would be issued to the reporting person. The Issuer completed a financing on November 5, 2013.
- These warrant shares were acquired in a recent offering by the Issuer of common stock and warrants whereby a purchase of each share of common stock included a warrant exercisable for one share of common stock at $2.50 per share.